Prehab_2: Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.

Sponsor
St. Borbala Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04595604
Collaborator
Biological Research Centre, Szeged (Other)
500
2
2
120
250
2.1

Study Details

Study Description

Brief Summary

Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks.

ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery.

Trimodal Prehabilitation Program is a recently introduced preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients.

This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol.

Additionally the effect of trimodal prehabilitation on gut microbiom diversity and its relation to clinical outcome will be analyzed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Trimodal rehabilitation + ERAS
  • Procedure: ERAS + nutritional prehabilitation
N/A

Detailed Description

Aim:

Colorectal cancer patients with a planned resection are tested if a complex, trimodal rehabilitation program can hold functional and morbidity benefit for them.

In the prospective, randomized (2:1) study control patient group will be the well established and tested ERAS (enhanced recovery after surgery) Program.

Study protocol in details:

First visit: Outpatient Department of Surgery

On both arms:
  • History taking (including family history and oncologic history);

  • Physical examination

Operation indication, type of procedure and date of procedure agreed; Organizing further investigations, anesthesia; Operative risk assessment ("ACS - surgical risk calculator"); Study patient identifier Nr generated; Nurse-led ERAS/Prehab clinic: randomization

On both arms:
  • Randomization (Prehabilitation Program / ERAS Program). 2:1

  • Nurse led clinic assessment ("study nurse"):

.i. CaseReportForm (CRF) filled in.

.ii. Patient data (personal data, demographics, history) .iii. Anthropometrics (BMI, MUST, Body fat % measurement). .iv. Mental hygienic status assessment (smoking, alcohol consumption, anxiety, depression, sleeping disorders).

.v. Cardiovascular status (resting HR, RR). .vi. Operative risk assessment (CR-Possum score). .vii. Preoperative counseling (operation type, preparation, pain management, discharge plan).

.viii. Preoperative nutritional planning (education, nutrient prescription). .ix. Alcohol intake and smoking cessation - information given. .x. Stoma education started. . xi. Consent signed, patient workbook handed over. .xii. Respiratory test referral. xiii. Fecal sample collected and stored at -86 C.

Physiotherapy, first visit

Both on control and interventional arms:
  • Respiratory function test recorded.

  • Physical status tested (6MWD) on a treadmill.

Just on Prehabilitation arm:
  • Respiratory training education.

  • Respiratory trainer device usage educated.

  • Daily activity (walking) planned.

Physiotherapy - second/third/fourth visit (weekly)

Just on Prehabilitation arm:

Previous week activity reviewed as to workbook. Physical assessment: 6MWD, FVC. Next week activity planned. Psychic preparation

Just on Prehabilitation arm:

• Once a week half an hour group relaxation training - regardless of the stage of prehabilitation program.

Admission to the Surgical Ward a day before surgery

Both on control and interventional arm:
  • Preoperative assessment:

.i. Anthropometrics (BMI, body fat%). .ii. Cardiovascular stage (resting HR and RR), ECG. .iii. Respiratory function tests. .iv. Physical status (6MWD) .v. Mental status (Hospital Anxiety and Depression Scale (HADS)) assessment. vi. Fecal sample collected and stored at -86 C.

  • Preoperative preparation (as to ERAS protocol).

  • Postoperative care (ITU, pain management, mobilization, oral nutrition built up, drains early removal, complications recorded (Clavien-Dindo-classification)).

  • Stoma education.

Dietary education. On discharge: Quality of Life (QoL) SF36 - (36-Item Short Form Survey from the RAND Medical Outcomes Study).

Postoperative follow up:
Both on control and interventional arms:

• Assessment (8th week post op.):

.i. Anthropometrics (BMI, Body fat %) .ii. Cardiovascular status (resting HR and RR). .iii. Respiratory function tests. .iv. Physical status (6MWD). .v. Fecal sample collected and stored at -86 C.

  • Long-term follow-up: 12, 24, 36, 48 and 60 months post operative assessment: Behavioral changes (alcohol abstinence, smoking cessation) Daily physical activity routine assessment. SF36 quality of life assessment Oncological outcome: local recurrence rate, distant recurrence rate, disease free survival, overall survival.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
500 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients planned for elective, curative operations for colorectal cancer will be randomized into two groups: experimental group will take part in a dedicated 4-week multimodal preparation program followed by ERAS preoperative management, while control group will just participate in the ERAS program without specific physical and mental preparation. 2:1 randomization will be performed for interventional and control armPatients planned for elective, curative operations for colorectal cancer will be randomized into two groups: experimental group will take part in a dedicated 4-week multimodal preparation program followed by ERAS preoperative management, while control group will just participate in the ERAS program without specific physical and mental preparation. 2:1 randomization will be performed for interventional and control arm
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Investigators and assessors will be blinded regarding preoperative preparation. Both randomization process and rehabilitation process will be carried out by a trained nurse, physiotherapist and psychotherapist, neither of them will be involved in outcome assessment.
Primary Purpose:
Prevention
Official Title:
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
Actual Study Start Date :
Sep 7, 2020
Anticipated Primary Completion Date :
Sep 7, 2025
Anticipated Study Completion Date :
Sep 7, 2030

Arms and Interventions

Arm Intervention/Treatment
Experimental: Trimodal prehabilitation + ERAS

Patients receiving a formal preoperative preparation on: Physical status (walking, respiratory training) Nutrition (nutritional supplements) Mental status (weekly groups led by clinical psychologist on anxiety and depression management). Each patient will be treated in an ERAS program preoperatively.

Procedure: Trimodal rehabilitation + ERAS
Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.
Other Names:
  • Prehabilitation
  • Active Comparator: ERAS + nutritional prehabilitation

    Each patient will be treated in an ERAS program preoperatively. No specific preoperative training will be involved apart from nutritional status assessment and nutritional supplements.

    Procedure: ERAS + nutritional prehabilitation
    Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.
    Other Names:
  • Enhanced Recovery After Surgery
  • Outcome Measures

    Primary Outcome Measures

    1. Length of hospital stay [45 days]

      Postoperative length of hospital stay in days.

    2. Number of days spent on ICU (Intensive care unit). [45 days]

      Number of days observed on ICU right after operation.

    3. Morbidity (early) classified after Clavien-Dindo. [7 days (until 8th postoperative day) postoperative]

      7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.

    4. Morbidity (long term) classified after Clavien-Dindo. [30 days (until 31st postoperative day)]

      30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.

    5. 30-day mortality [30 days (until 31st postoperative day)]

      30-day mortality of each patient will be recorded.

    6. 90-day mortality [90 days (until 91st postoperative day)]

      90-day mortality of each patient will be recorded.

    7. Change in preoperative functional status - 6MWD by operation [Measured points: 4 weeks before surgery, on day of hospital admission]

      6MWD (6-minute walking distance test)

    8. Change in postoperative functional status - 6MWD by the end of rehabilitation [Measured points: 4 weeks before surgery, 8 weeks after operation]

      6MWD (6-minute walking distance test)

    9. Change in preoperative functional status - FVC by operation [Measured points: 4 weeks before surgery, on day of hospital admission]

      Measured points: 4 weeks before surgery, on day of hospital admission

    10. Change in preoperative functional status - FVC by the end of rehabilitation [Measured points: 4 weeks before surgery, 8 weeks after operation]

      Measured points: 4 weeks before surgery, 8 weeks after operation

    Secondary Outcome Measures

    1. Change of alpha- and beta-diversity of fecal microbata [Measured points: 4 weeks before surgery, on day of hospital admission and 8 weeks after surgery]

      Fecal microbara diversity will be measured at diagnosis, at the time of operation and 8 weeks after operation. We will assess diversity changes related to the intervention.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patient with histologically proven primary colorectal adenocarcinoma

    • any stage of colorectal cancer

    • elective operation

    • curative intention

    • informed consent signed by patient

    Exclusion Criteria:
    • emergency operation

    • palliative operation

    • non-colorectal, second malignancy

    • pregnancy

    • patient not giving consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Surgery, St. Borbala Hospital Tatabánya Hungary 2800
    2 St. Borbala Hospital Tatabánya Hungary 2800

    Sponsors and Collaborators

    • St. Borbala Hospital
    • Biological Research Centre, Szeged

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    St. Borbala Hospital
    ClinicalTrials.gov Identifier:
    NCT04595604
    Other Study ID Numbers:
    • ERASvsPrehab_2
    First Posted:
    Oct 20, 2020
    Last Update Posted:
    Oct 20, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by St. Borbala Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 20, 2020